Keywords: Takeda, Dainippon Sumitomo, Licensing, Lurasidone, Schizophrenia, Ceftaroline, Antibiotics, European management
Takeda links with Dainippon Sumitomo on two licensing deals; makes European management appointments
Article | 01 April 2011
Japanese drugmaker Dainippon Sumitomo Pharma (4506: JP) has entered into a licensing accord with Takeda Pharmaceutical (TSE: 4502) for the joint development ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
